Viridian Therapeutics has been in an accumulation phase since 2020. Moreover, the price has recently moved above EMAs (10, 21 and 30) with price gap and significant volume increase.
I think price will continue its mark up phase in the next days.
IMPORTANT: This is not financial advice.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。